Spero Therapeutics, Inc.
They are a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections.
$14.00 - $16.00
November 2, 2017
BofA Merrill Lynch, Cowen & Company, Stifel
To view the prospectus for Spero Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277